GSK plc Adjustments For Reconcile Profit Loss
GSK plc (GLAXF) reported Adjustments For Reconcile Profit Loss of GBP 2.65 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2026-03-06
| Period end | Adjustments For Reconcile Profit Loss 12 month | Adjustments For Reconcile Profit Loss 12 month as first filed |
|---|---|---|
| 2025-12-31 | 2.65B GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 4.91B GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 2.79B GBP 20-F · filed 2026-03-06 | -2.79B GBP 20-F · filed 2024-03-05 |
| 2022-12-31 | 3.02B GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | -3.73B GBP 20-F · filed 2024-03-05 | 4.15B GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 2.57B GBP 20-F · filed 2023-03-10 | 3.71B GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 4.26B GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 5.70B GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 6.09B GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 7.04B GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | -3.74B GBP 20-F/A · filed 2018-03-20 |